» Articles » PMID: 17074423

Influenza- and RSV-associated Hospitalizations Among Adults

Overview
Journal Vaccine
Date 2006 Nov 1
PMID 17074423
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

We estimated influenza- and respiratory syncytial virus (RSV)-associated hospitalizations by age, high-risk status and outcome, during the 1996/1997-1999/2000 respiratory seasons among adults who did not receive influenza vaccine. Using three health maintenance organization (HMO) databases and local viral surveillance data, we identified weeks when influenza and RSV were circulating and estimated influenza- and RSV-associated hospitalizations. Persons aged > or = 65 years with and without high-risk conditions had significantly increased rates of influenza-associated hospitalizations for pneumonia and influenza, and circulatory and respiratory diseases. Persons aged > or = 65 years with high-risk conditions also had significantly increased rates of influenza-associated hospitalizations for cardiac conditions (16.9 per 10,000 person periods). Relative to the influenza estimates for high-risk persons > or = 65 years, we found lower rates of RSV-associated hospitalizations for pneumonia and influenza diseases (23.4 per 10,000 person periods), cardiac diseases (4.3 per 10,000 person periods) and circulatory and respiratory diseases (44.0 per 10,000 person periods). Among low-risk persons aged 50-64 years, we did not identify significantly elevated rates of influenza- or RSV-associated hospitalizations. Excess hospitalization estimates among adults aged > or = 65 years and high-risk 50-64 year olds during the influenza season suggest that these groups should have priority for influenza vaccine during vaccine shortages.

Citing Articles

Burden of Respiratory Syncytial Virus-Associated Hospitalizations in US Adults, October 2016 to September 2023.

Havers F, Whitaker M, Melgar M, Pham H, Chai S, Austin E JAMA Netw Open. 2024; 7(11):e2444756.

PMID: 39535791 PMC: 11561688. DOI: 10.1001/jamanetworkopen.2024.44756.


A Model-Based Estimation of RSV-Attributable Incidence of Hospitalizations and Deaths in Italy Between 2015 and 2019.

Meroc E, Liang C, Iantomasi R, Onwuchekwa C, Innocenti G, dAngela D Infect Dis Ther. 2024; 13(11):2319-2332.

PMID: 39289329 PMC: 11499556. DOI: 10.1007/s40121-024-01041-x.


Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.

Grohskopf L, Ferdinands J, Blanton L, Broder K, Loehr J MMWR Recomm Rep. 2024; 73(5):1-25.

PMID: 39197095 PMC: 11501009. DOI: 10.15585/mmwr.rr7305a1.


Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019.

Polkowska-Kramek A, Begier E, Bruyndonckx R, Liang C, Beese C, Brestrich G Infect Dis Ther. 2024; 13(4):845-860.

PMID: 38520629 PMC: 11058748. DOI: 10.1007/s40121-024-00951-0.


Estimated Respiratory Syncytial Virus-Related Hospitalizations and Deaths Among Children and Adults in Spain, 2016-2019.

Haeberer M, Bruyndonckx R, Polkowska-Kramek A, Torres A, Liang C, Nuttens C Infect Dis Ther. 2024; 13(3):463-480.

PMID: 38319540 PMC: 10965866. DOI: 10.1007/s40121-024-00920-7.